Integra Lifesciences Holdings Corp’s recently made public that its SVP, Fin & Princ Acct Officer Mosebrook Jeffrey unloaded Company’s shares for reported $25701.0 on Aug 19 ’24. In the deal valued at $21.58 per share,1,191 shares were sold. As a result of this transaction, Mosebrook Jeffrey now holds 36,088 shares worth roughly $0.61 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, ESSIG STUART bought 52,641 shares, generating $1,499,979 in total proceeds. Upon buying the shares at $28.49, the Exec. Chairman of the Board now owns 487,922 shares.
Before that, HILL BARBARA B bought 36,350 shares. Integra Lifesciences Holdings Corp shares valued at $995,816 were divested by the Director at a price of $27.40 per share. As a result of the transaction, HILL BARBARA B now holds 36,350 shares, worth roughly $0.62 million.
Citigroup downgraded its Integra Lifesciences Holdings Corp [IART] rating to a Sell from a a Neutral in a research note published on July 30, 2024; the price target was decreased to $23 from $30. A number of analysts have revised their coverage, including BTIG Research’s analysts, who decreased its forecast for the stock in late July from “a Neutral” to “a Sell”. Wells Fargo also remained covering IART and has decreased its forecast on May 07, 2024 with a “an Equal weight” recommendation from previously “an Overweight” rating. Oppenheimer revised its rating on May 07, 2024. It rated IART as “a Perform” which previously was an “an Outperform”.
Price Performance Review of IART
On Friday, Integra Lifesciences Holdings Corp [NASDAQ:IART] saw its stock jump 0.29% to $17.00. Over the last five days, the stock has lost -4.87%. Integra Lifesciences Holdings Corp shares have fallen nearly -60.96% since the year began. Nevertheless, the stocks have fallen -54.71% over the past one year. While a 52-week high of $45.42 was reached on 02/20/24, a 52-week low of $16.81 was recorded on 10/03/24. SMA at 50 days reached $20.14, while 200 days put it at $31.06.
Levels Of Support And Resistance For IART Stock
The 24-hour chart illustrates a support level at 16.82, which if violated will result in even more drops to 16.64. On the upside, there is a resistance level at 17.32. A further resistance level may holdings at 17.65. The Relative Strength Index (RSI) on the 14-day chart is 33.42, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.37, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 87.38%. Stochastics %K at 15.42% indicates the stock is a buying.
How much short interest is there in Integra Lifesciences Holdings Corp?
A steep rise in short interest was recorded in Integra Lifesciences Holdings Corp stocks on 2024-09-13, dropping by -0.22 million shares to a total of 4.57 million shares. Yahoo Finance data shows the prior-month short interest on 2024-08-15 was 4.79 million shares. There was a decline of -4.92%, which implies that there is a negative sentiment for the stock.
